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Summary
The interactions of microtubules with most com-
pounds described as stabilizing agents have been
studied. Several of them (lonafarnib, dicumarol, lutein,
and jatrophane polyesters) did not show any stabilizing
effect on microtubules. Taccalonolides A and E show
paclitaxel-like effects in cells, but they were not able
to modulate in vitro tubulin assembly or to bind micro-
tubules, which suggests that other factors are involved
in their cellular effects. The binding constants of epo-
thilones, eleutherobin, discodermolide, sarcodictyins,
3,17b-diacetoxy-2-ethoxy-6-oxo-B-homo-estra-1,3,5(10)-
triene, and dictyostatin to the paclitaxel site; the critical
concentrations of ligand-induced assembly; and their
cytotoxicity in carcinoma cells have been measured,
and correlations between these parameters have been
determined. The inhibition of cell proliferation cor-
relates better with the binding enthalpy change than
with the binding constants, suggesting that large, fa-
vorable enthalpic contribution to the binding is desired
to design paclitaxel site drugs with higher cytotoxicity.
Introduction
Tubulin assembly modulators represent an important
class of antitumor drugs, as they have been proven to be
an effective tool for cancer chemotherapy [1]. There are
two major classes of tubulin assembly modulators: (1)
compounds like vinblastine or colchicine, which depoly-
merize microtubules and block the mitotic spindle [2, 3],
thus arresting dividing cells in mitosis with condensed
chromosomes; and (2) compounds like paclitaxel (Taxol
[Bristol-MyersSquibb], 4,10-diacetoxy-2a-(benzoyloxy)-
*Correspondence: fer@cib.csic.es5b,20-epoxy-1,7b-dihydroxy-9-oxotax-11-en-13a-yl(2R,
3S)-3[(phenylcarbonyl) amino]-2-hydroxy-3-phenylpro-
pionate), which promote tubulin polymerization into
microtubules (so called microtubule-stabilizing agents,
MSAs) and block microtubule dynamics, leading to ab-
normal mitosis and subsequent apoptosis [4, 5]. Both
microtubule depolymerizers and microtubule stabilizers
at low concentrations can arrest dividing cells in mitosis,
without altering microtubule mass, by blocking microtu-
bule dynamics [6]. Paclitaxel was the first MSA discov-
ered [7]; it promotes the in vitro assembly of tubulin in
the absence of GTP, which is normally required for mi-
crotubule assembly; and the microtubules formed are
stable against conditions favoring depolymerization,
such as cold temperature, Ca2+, and dilution [7]. In cells,
paclitaxel induces microtubule stabilization and charac-
teristic microtubule bundles [8]. However, despite the
clinical success of paclitaxel and docetaxel (a closely
related analog; Taxotere [Aventis RP56976], 4-acetoxy-
2a-(benzoyloxy)-5b,20-epoxy-1,7b,10b-trihydroxy-9-
oxotax-11-en-13a-yl(2R,3S)-3-[(tert-butoxycarbonyl)
amino]-2-hydroxy-3-phenylpropionate) against ovarian,
metastatic breast, head and neck, and lung cancer [9],
both have two factors that limit their applicability: they
have relatively low aqueous solubility, and they develop
pleiotropic drug resistance mediated by the overexpres-
sion of the P-glycoprotein [10, 11]. Moreover, it has been
shown that cultured ovarian tumor cells exposed to
paclitaxel develop resistance through mutations in b-
tubulin [12].
The clinical successes of paclitaxel (Taxol) and doce-
taxel (Taxotere) have triggered the search for new agents
with similar mechanisms of action but without their dis-
advantages, i.e., higher solubility in aqueous solutions,
poorer substrates of P-glycoprotein, and easier total
chemical synthesis. Screenings of natural products
from various sources (including corals, marine sponges,
bacteria, and plants) have found an increasing number of
structurally unrelated compounds that stabilize microtu-
bules and mimic the activity of paclitaxel/docetaxel [13].
These MSA compounds can be classified into three
groups with respect to their mechanism of action. The
first group of compounds includes those that bind to
the paclitaxel site in microtubules. Epothilones, eleuther-
obin, discodermolide, sarcodictyins, an estradiol analog
(3,17b-diacetoxy-2-ethoxy-6-oxo-B-homo-estra-1,3,5
(10)-triene), cyclostreptin (also called FR182877 and
WS9885B), dictyostatin, paclitaxel, and docetaxel bind
to the same, or overlapping, taxoid binding site, as has
been demonstrated by competition with 3H-paclitaxel or
Flutax-2 (a fluorescent derivative of paclitaxel; (7-O-[N-
(2,7-difluoro-4’-fluoresceincarbonyl)-L-alanyl]paclitaxel)
[14–20] (see the chemical formulas in Figure 1A).
The second group of compounds is the group formed
by those that bind the laulimalide binding site; this group
comprises two ligands, laulimalide itself [20] and peloru-
side A, which has recently been described to bind to this
site [21].
The third group would include those compounds that
have been described as having, actually or potentially,
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1271microtubule stabilizing activity but whose binding to mi-
crotubules has not been described; this group would in-
clude the plant steroids taccalonolides A and E [22];
some xanthophylls that have been described as possi-
ble endogenous ligands for the paclitaxel binding site
in the macula [23]; dicumarol and its analog coumadin
[24], which have anticoagulant activity [25]; jatrophane
polyesters [26]; and lonafarnib (Sch66336), a farnesyl
transferase inhibitor that has been recently described
to bundle microtubules in cells and seems to act by in-
hibiting tubulin deacetylase [27] (see the chemical for-
mulas in Figure 1A).
Our first goal was to characterize the molecular mech-
anisms underlying the microtubule stabilization induced
by each of these compounds in order to determine
whether they directly bind to the microtubules and ther-
modynamically stabilize them. To do this, we have tested
all of these ligands for their ability to induce or modulate
tubulin assembly in vitro, and we have checked to see if
they are able to bind to microtubules and to the paclitaxel
site.
From the 19 compounds studied in this work, we have
found that only 11 of them were able to modify tubulin
assembly in vitro and bind to the paclitaxel site at the mi-
crotubule. We have measured the binding of these 11 li-
gands of the paclitaxel binding site, the critical concen-
trations of the ligand-induced in vitro tubulin-GTP and
tubulin-GDP assembly, and the cytotoxicities in 1A9
and A549 human carcinoma cells, as well as their effect
on A549 interphase microtubules, nuclear morphology,
mitotic aberrations, and cell cycle progression of U937
leukemia cells. We also explored the correlations be-
tween binding to the paclitaxel site and these microtu-
bule-mediated effects, in search of useful hints for ratio-
nal drug design. In this way, we have found a predictive
value of the enthalpic contribution to the free energy of
binding for the rational design of new paclitaxel site-
directed drugs with higher cytotoxicity.
Results and Discussion
Epothilones A and B (7,11-Dihydroxy-8,8,10,12-tetra-
methyl-3-[1-methyl-2-(2-methyl-thiazol-4-yl)-vinyl]-4,17-
dioxa-bicyclo [14.1.0] heptadecane-5,9-dione), sarco-
dictyins A and B, eleutherobin, a estradiol analog,
discodermolide, dictyostatin, and docetaxel, have
been described to bind to the paclitaxel site at the mi-
crotubules, either by competing with 3H-paclitaxel [15,
16, 28] or by displacing a fluorescent labeled paclitaxel
(Flutax-2) [20, 29], but little is known about the mecha-
nisms of action of these and the rest of the compounds
that stabilize microtubules. In this work, we have classi-
fied most of the compounds described as microtubule-
stabilizing agents on the basis of their mechanisms of
action. Furthermore, we have studied their binding and
explored the relationships between binding thermody-
namics, tubulin assembly, and cytotoxicity of all of thepaclitaxel site ligands. Laulimalide and peloruside A,
which bind to a distinct site, have been studied sepa-
rately [20, 21].
Effect of the Ligands on Interphase Microtubules,
Mitotic Spindles, Nuclear Morphology, and Cell
Cycle
First of all, the effect of the ligands on the interphase mi-
crotubules, mitotic spindles, nuclear morphology, and
cell cycle of tumor cells was examined comparatively.
Human lung carcinoma A549 cells, incubated for 24 hr
with three serial dilutions of each ligand, were used to
characterize the effects of the ligands on the microtubule
cytoskeleton and nuclear morphology. Indirect inmuno-
fluorescences (Figure 1B) showed that 100 nM paclitaxel
(Figure 1B[B]), 100 nM docetaxel (not shown), 100 nM
epothilone B (Figure 1B[C]), 500 nM epothilone A (not
shown), 100 nM dictyostatin (Figure 1B[D]), 100 nM dis-
codermolide (Figure 1B[E]), 500 nM eleutherobin (Figure
1B[F]), and 500 nM cyclostreptin (Figure 1B[H]) induced
many bundles and also multipolar spindles and micro-
nucleated cells (not shown). Both 100 nM dictyostatin
and 100 nM discodermolide were found to be more ac-
tive in inducing bundles than the other ligands. Sarcodic-
tyin A (1, 5, and 10 mM, [Figure 1B[G]]) and sarcodictyin B
(1, 5, and 10 mM, not shown) induced few bundles made
up of long microtubules; the cells treated with those li-
gands had no multipolar spindles and few multiple mi-
cronuclei. With 20 mM of the estradiol analog, neither ef-
fects on interphase microtubules nor multipolar spindles
or micronucleated cells were observed. Taccalonolides
also showed paclitaxel-like effects on A549 cells: 5 mM
taccalonolide A and 10 mM taccalonolide E induced bun-
dles, multipolar spindles, and multiple micronuclei (re-
sults not shown).
Lonafarnib (5, 10, 20, and 40 mM), luteine, dicumarol,
and jatrophane polyesters (Figures 1B [B–D], up to 20
mM) did not induce bundles, and neither micronucleated
cells nor multipolar spindles were observed in our prep-
arations, which were similar to those of control, un-
treated cells (Figure 1B[A]).
Cell cycle analysis was performed on monocytic leu-
kemia U937 cells incubated for 20 hr in the presence of
five serial dilutions of each ligand. The smallest concen-
tration that gave maximal accumulation of cells in the
G2+M phase (Table S1; see the Supplemental Data avail-
able with this article online) was 5 nM paclitaxel, 2.5 nM
docetaxel, 25 nM epothilone A, 5 nM epothilone B, 7.5
nM dictyostatin, 25 nM discodermolide, 50 nM eleuther-
obin, 0.5 mM sarcodictyin A, 0.5 mM sarcodictyin B, 100
nM cyclostreptin, 2.5 mM taccalonolide A, and 10 mM tac-
calonolide E. In all cases, a sub-G1 peak, presumably of
cells undergoing apoptosis, appeared (Table S1). With
the estradiol analog, no accumulation was observed in
the G2+M phase at concentrations up to 40 mM.
Lonafarnib (up to 20 mM), lutein (up to 40 mM), dicuma-
rol (up to 40 mM), and jatrophane polyesters B, C, and DFigure 1. Compounds Used in the Study and Their Effect on Interphase Microtubules
(A) Chemical formulas of the ligands studied.
(B) Comparative effect of the ligands on interphase microtubules. A549 cells were incubated for 24 hr in the presence of drug vehicle (A) or
100 nM paclitaxel (B), 100 nM epothilone B (C), 100 nM dictyostatin (D), 100 nM discodermolide (E), 500 nM eleutherobin (F), 1 mM sarcodictyin
A (G), and 500 nM cyclostreptin (H). The bar indicates 10 mm.
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Ligand Cr-GTP (mM) Cr-GDP (mM) IC50 1A9 (nM) IC50 A549 (nM)
Paclitaxel (1) 4.23 6 0.2a 10.29 6 0.7 1.0 6 0.4 1.4 6 0.2
Docetaxel (2) 1.52 6 0.1a 5.92 6 1.0 0.4 6 0.2 3.0 6 0.3
Epothilone A (3) 5.11 6 0.5a 8.98 6 0.4 4.1 6 1.0 7.5 6 1.4
Epothilone B (4) 1.17 6 0.6a 5.60 6 0.1 1.2 6 0.3 0.8 6 0.1
Dictyostatin (5) 0.66 6 0.1 2.40 6 0.2 3.6 6 1.0 5.6 6 1.0
Discodermolide (6) 0.92 6 0.04 3.81 6 0.9 17.6 6 2.7 6.6 6 0.8
Eleutherobin (7) 6.50 6 0.1 12.8 6 1.0 13.2 6 7.0 3.3 6 0.2
Sarcodictyin A (8) >60b Inactive 32 6 21 36 6 12
Sarcodictyin B (9) >60b Inactive 103 6 18 50 6 15
Estradiol analog (10) >60b Inactive 43,000 6 3,000 >20,000
Cyclostreptin (11) w30b Inactive 40 6 5 37 6 8
Critical concentrations of the ligand-induced GTP- or GDP-tubulin assembly in buffer PEDTA4 with 1 mM GTP or 1 mM GDP in the presence of
the corresponding ligand (data6 standard error). IC50 of the ligands against 1A9 human ovarian carcinoma cells and A549 human lung carcinoma
cells (data 6 standard error; average of at least four independent experiments).
a Data from [33].
b Although microtubules were observed in the pellets, much higher concentrations of tubulin and drugs would be required for a precise measure-
ment of critical concentrations.(up to 40 mM) did not significantly arrest cells in the
G2+M phase in our experimental conditions, but a sub-
G1 peak of hypodiploid cells appeared (Table S1).
We concluded from these cellular results that the only
compounds that behaved like paclitaxel were docetaxel,
epothilone A, epothilone B, dictyostatin, discodermo-
lide, eleutherobin, sarcodictyin A, sarcodictyin B, cyclo-
streptin, and taccalonolides A and E.
Ligand-Induced Assembly of Tubulin
The characteristic effect of these ligands is microtubule
thermodynamic stabilization, so we checked if the li-
gands were able to induce tubulin assembly in a pure
GTP-tubulin or GDP-tubulin system and then measured
the critical concentrations (Cr) of the assembly reaction
(Table 1), in a buffer in which tubulin is unable to self-
assemble in the absence of ligand (Cr > 200 mM for
GTP-tubulin; [30]).
Paclitaxel (compound 1), docetaxel (compound 2),
epothilones A (compound 3) and B (compound 4), dic-
tyostatin (compound 5), discodermolide (compound 6),
eleutherobin (compound 7), sarcodictyin A (compound
8) and sarcodictyin B (compound 9), an estradiol analog
(compound 10), cyclostreptin (compound 11), taccalo-
nolides A (compound 12) and E (compound 13), lutein
(compound 14), dicoumarol (compound 15), jatrophane
polyesters 13B (compound 16), jatrophane polyesters
13C (compound 17), jatrophane polyesters 13D (com-
pound 18), lonafarnib (Sch66336; compound 19), and,
as control, the solvent in which the drugs are dissolved
(DMSO, called compound 20) were tested for their ability
to induce purified tubulin assembly.
The strongest assembly inductor is dictyostatin, with
a Cr of 0.66 6 0.06 mM for GTP-tubulin and one of
2.40 6 0.2 mM (Table 1) for GDP-tubulin, more than five
times below than that for paclitaxel (Cr of 4.23 6 0.22
mM for GTP-tubulin and 10.29 6 0.69 mM for GDP-tubu-
lin). Both sarcodictyins A and B, cyclostreptin, and the
estradiol analog weakly induced assembly at high con-
centrations of GTP-tubulin (we checked by electron mi-
croscopy that the pelleted polymers were microtu-
bules), but their critical concentrations were not
precisely determined since no constant concentration
of tubulin was reached in the supernatants. Precisemeasurements of these Cr would require higher concen-
trations of tubulin and drugs, which were not possible to
reach because of the limited amounts of available drug.
Furthermore, no assembly was detected in GDP-tubulin
experiments for these ligands.
No ligand-induced polymerization was observed in
the absence of Mg+2 for ligands 1–11, indicating that
the assembly induced by all of these ligands is depen-
dent on Mg+2, as is the case of paclitaxel and docetaxel,
requiring free mM concentrations of Mg+2 [30]. Never-
theless, a weak assembly has been observed for disco-
dermolide with much lower concentrations of Mg+2 in
the nanomolar range by using high concentrations of
tubulin (data not shown).
Electron microscopy was performed on all of the in-
duced polymers, and these were normal microtubules.
Figure 2A shows morphologically normal microtubules
induced by the weakest ligands (both sarcodictyins
A and B and the estradiol analog) compared to
paclitaxel-induced microtubules.
Taccalonolides A and E; jatrophane polyesters 13B,
13C, and 13D; lutein; lonafarnib; and dicoumarol were
not able to induce assembly at concentrations as high
as 60 mM GTP-tubulin (and 66 mM ligand), as checked
by centrifugation and electron microscopy.
Effects of the Ligands on Microtubule Assembly
In order to check if the ligands that cannot induce puri-
fied tubulin assembly could at least modulate tubulin as-
sembly, i.e., modify the critical concentration in condi-
tions in which purified tubulin is able to assemble
(GAB [glycerol assembly buffer; 3.4 M glycerol, 10 mM
sodium phosphate, 1 mM EGTA, 6 mM MgCl2 (pH
6.5)]-1 mM GTP buffer), 15 and 20 mM pure GTP-tubulin
were incubated at 37ºC in this buffer in the presence of
16.5 and 22 mM ligand, respectively. Under these condi-
tions, tubulin assembles in the absence of exogenous li-
gands with a critical concentration of 3.36 0.02 mM. Fig-
ure 2B shows how the compounds modify the critical
concentration of the assembly. Compounds 1–11 de-
crease the critical concentration necessary for polymer-
ization, as expected from their capacity to induce GTP-
tubulin assembly (Table 1). Compounds 12 and 13 and
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have as very weak depolymerizers.
Finally, we checked if those ligands that do not affect
microtubule assembly in pure tubulin systems could be
affecting other proteins in the in vitro microtubule as-
sembly system. Thus, we performed similar experi-
ments with microtubular protein, i.e., in the presence
of microtubule-associated proteins (MAPs). Ligands
that do not affect microtubule assembly in purified tubu-
lin assembly systems were inactive, and lonafarnib be-
haved as a weak depolymerizer (data not shown).
On the basis of the microtubule assembly results, we
can conclude that ligands 12–19 (including taccalonolide
A and E; jatrophane polyesters 13B, 13C, and 13D; lona-
farnib; lutein; and dicoumarol) do not induce or promote
microtubule assembly in our in vitro systems, at least un-
der the conditions that we have assayed in this work,
suggesting that any microtubule stabilizing activity of
some of these ligands would come from the interaction
with other factors in any of the signaling pathways that
may be regulating microtubule stability.
Binding of the Ligands to the Paclitaxel Site
We next checked the ligands for their ability to displace
Flutax-2 (a bona fide probe of the paclitaxel binding site)
[20, 29, 31]. To do so, increasing concentrations of li-
Figure 2. Ligand-Induced Microtubule Assembly
(A) Electron micrographs of ligand-induced microtubules. 30 mM tu-
bulin and 33 mM ligand were incubated at 37ºC for 30 min, and 20 ml
of the samples was adsorbed onto formvar/carbon-coated grids
and stained with 1% uranyl acetate. The scale bar indicates 100 nm.
(B) Critical concentration of the GTP-tubulin assembly at 37ºC in
buffer GAB-1 mM GTP in the presence of 10% excess of the ligands
as compared with the control (20, DMSO, dotted line). Ligands: pac-
litaxel (1) and docetaxel (2), epothilone A (3), epothilone B (4), dic-
tyostatin (5), discodermolide (6), eleutherobin (7), sarcodictyin A
(8), sarcodictyin B (9), an estradiol analog (10), cyclostreptin (11), tac-
calonolide A (12), taccalonolide E (13), lutein (14), dicoumarol (15),
polyester jatrophane 13B (16), polyester jatrophane 13C (17), polyes-
ter jatrophane 13D (18), lonafarnib (19), and, as control, the solvent in
which the drugs are dissolved (DMSO, [20]).
The error bars indicate standard error.gand up to 100 mM against a mixture of 50 nM cross-
linked microtubules and 50 nM Flutax-2 were used (Fig-
ure 3A). Compounds 1–11 were able to displace Flutax-2
from its site, indicating that all of them bind to the pacli-
taxel or an overlapping site at the microtubule. As ex-
pected, compounds 14–19 were not able to displace
Flutax-2, indicating that they do not interact with the
paclitaxel binding site.
Taccalonolides A and E (compounds 12 and 13, re-
spectively) weakly and slowly displaced Flutax-2 from
its site in our standard displacement test. Full displace-
ment of 50 nM Flutax-2 by 50 mM taccalonolide A takes
Figure 3. Binding of Ligands to the Paclitaxel Site
(A) Competition between Flutax-2 and the ligands for the paclitaxel
binding site. Displacement of the fluorescent taxoid Flutax-2
(50 nM) from microtubule binding sites (50 nM) by the ligands at
35ºC. The points are data (and standard errors), and the lines
were generated with the best-fit value of the binding equilibrium
constant of each ligand, assuming a one to one binding to the
same site. Dark blue, discodermolide; purple, dictyostatin; green,
eleutherobin; black, paclitaxel; gray, sarcodictyin B; light blue, sar-
codictyin A; and yellow, estradiol analog.
(B) Binding of ligands to crosslinked microtubules. 30 mM of pacli-
taxel binding sites in crosslinked microtubules were incubated with
equimolecular amounts of the desired ligands and harvested by
centrifugation, the bound ligand was extracted from the protein
pellet, and the supernatant and analyzed by HPLC as described
in the text. Each injection contains equivalent amounts of extract.
Supernatant traces have been displaced 0.1 absorbance units for
presentation purposes.
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(less than 4 min for 99% equilibrium) that can be calcu-
lated from the kinetic dissociation constant of Flutax-2
(1.92 3 1022 s21 [32]). (The observed kinetic rate of dis-
sociation of Flutax-2 from its binding site corresponds
to the slowest reaction, which is either the dissociation
of Flutax-2 from its site or the association of the taccalo-
nolide to the sites left empty. In the second case, the dis-
placement kinetics should be dependent upon the con-
centration of taccalonolide, which is not the case.) So,
to confirm that we were observing a true displacement,
we performed similar experiments by centrifugation.
No Flutax-2 displacement by taccalonolides or inhibition
of Flutax-2 binding after preincubation of the micro-
tubules with taccalonolides was seen, indicating that
the observed decrease of the Flutax-2 anisotropy was
artifactual. Moreover, since neither effects on the poly-
merization nor direct binding to microtubule pellets, or
decreasing the free ligand-free concentration in the
supernatants after incubation with microtubules, was
observed by HPLC analysis (see below), we should con-
sider that both taccalonolides A and E are not in vitro
microtubule-stabilizing agents and that the effect ob-
served on cells is not due to theirbinding to microtubules.
Binding to Microtubules
We next checked whether direct evidence of the binding
to microtubules of the ligands that were able to induce or
modulate tubulin assembly could be obtained. Microtu-
bule pellets both from crosslinked (Figure 3B) and non-
crosslinked microtubules (not shown) were extracted
with dichloromethane and measured by HPLC; the li-
gands were found bound to the microtubules in the pellet
(except in the case of the low-affinity ligands, in which
part of the ligand was found in the supernatant). Appro-
priate controls were performed to confirm the solubility
of the ligands under the conditions of the experiment
(30 mM ligand and crosslinked microtubules was used
for these experiments). Figure 3B shows representative
results with paclitaxel, the estradiol analog, discodermo-
lide, and epothilone A. Similar results were obtained with
docetaxel, epothilone B, dictyostatin, eleutherobin, and
sarcodictyins A and B.
Interestingly, cyclostreptin was not observed in the
extracts of the microtubule pellets in these experiments,
even at higher concentrations (since this compound has
very low absorbance in the UV range, HPLC-mass spec-
trometry was used to detect it). However, a decrease in
the amount of ligand in the supernatant was observed
after incubation with microtubules. Since Flutax-2 dis-
placement had been observed for this compound (not
shown), we have investigated the nonreversible binding
of this compound to the microtubules, which has led to
the discovery of the covalent binding of cyclostreptin to
its binding site in the microtubules, which will be re-
ported separately (unpublished data).
Similar experiments were performed with taccalono-
lides A and E, and no evidence of binding to crosslinked
or native microtubules was found.
Thermodynamic Parameters of Ligand Binding to
the Paclitaxel Site
The binding constants and thermodynamic parameters
of compounds reversibly displacing Flutax-2 were cal-culated from the displacement isotherms (Figure 3A;
Experimental Procedures) at different temperatures
(Table 2).
The ligand with the highest binding affinity is discoder-
molide (Kapp discodermolide = 526 3 10
7 M21; Table 2),
with almost 500-fold higher affinity than paclitaxel (Kapp
paclitaxel = 1.073 107 M21) and around 150-fold affinity
than docetaxel (Kapp docetaxel = 3.09310
7 M21) at 37ºC.
Discodermolide has around 30 times more affinity for the
site than its cycled analog dictyostatin (Kapp dictyosta-
tin = 18.0 3 107 M21) and 8 times more affinity for the
site than epothilone B (Kapp epoB = 60.8 3 10
7 M21).
The weakest ligands are the estradiol analog and the
sarcodictyins (Kapp estradiol = 0.047 3 10
7 M21, Kapp
sarcA = 0.16 3 107 M21, Kapp sarcB = 0.20 3 10
7 M21).
Eleutherobin has a binding affinity in between those of
paclitaxel and docetaxel (Kapp eleutherobin = 1.36 3 10
7
M21). Compatible values for epothilones A and B (5 3
107 and 503 107 M21, respectively) [33] and discodermo-
lide (Kapp discodermolide = 500310
7 M21) were obtained
by using direct sedimentation measurements, which fur-
ther validates the Flutax-2 displacement method.
As for the case of paclitaxel and docetaxel, all of the li-
gands show a dependence of the apparent binding con-
stant on temperature. The binding reaction is exothermic
for all of the ligands; the higher the temperature, the
lower the binding constant. Binding is enthalpy driven
for paclitaxel, docetaxel, and epothilones A and B, and
it has a positive contribution (disfavorable) of the entro-
pic term (2TDS) to the free energy of binding, while all the
rest have a negative (favorable) entropic contribution
to the free energy. This is especially remarkable for dis-
codermolide, a ligand that should have a strong confor-
mational freedom in solution, which shows a large unex-
pected favorable entropic contribution to the free energy
of binding.
Comparison between Ligand Binding Affinities and
Tubulin Assembly Activity
In order to quantitatively compare microtubule assem-
bly induced by these ligands, we explored the correla-
tion between this activity and the binding affinity. The
comparison between the apparent affinity constants
(or free energy of binding, DG0app) of the ligands to their
site and the equilibrium constants for the microtubule
growth reaction, which is approximately the inverse of
the critical concentration [34], shows that they are corre-
lated (r2 = 0.58 for GTP-tubulin [Figure 4A]; r2 = 0.50 for
GDP-tubulin [Figure 4B]). Changes in the apparent free
energy of elongation are much smaller than those in
the free energy of binding (slope = 0.30 for GTP-tubulin
and 0.16 for GDP-tubulin). Similar results were obtained
for a set of chemically related epothilone analogs [33].
Although the elongation constant and binding affinity
would be expected not to be correlated, since they are
different reactions with different intrinsic equilibrium
binding constants (see the Supplemental Data in [33]),
the experimental results indicate that they are somehow
related, even for these chemically different compounds.
Docetaxel and dictyostatin, which are the most powerful
ligands inducing assembly, are over the best regression
line in both GTP- and GDP-tubulin assembly experi-
ments. The rest of the ligands lie inside the 95%
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].confidence interval of the regression, showing a good
linear correlation.
Comparison between Binding Thermodynamics and
Cytotoxicity
The IC50 of the ligands were determined (Table 1) in 1A9
and A549 cells. The most cytotoxic ligand in 1A9 cells is
docetaxel (IC50 = 0.4 6 0.2 nM), which is very similar to
paclitaxel (IC50 = 1.0 6 0.4 nM) and epothilone B
(IC50 = 1.26 0.3 nM). The ligand with the largest affinity,
discodermolide, has a relatively low cytotoxicity (IC50 =
17.6 6 2.7 nM in 1A9 cells and 6.35 6 0.8 in A549 cells),
while eleutherobin, a ligand with much lower affinity for
the site than paclitaxel, has a similar or even lower IC50
(13.2 6 7 nM in 1A9 cells and 3.3 6 0.2 nM) than disco-
dermolide.
Figure 5A shows a weak correlation of cytotoxicity
(IC50) with the binding affinity (free energy of binding)
(r2 = 0.31 for 1A9 cells; r2 = 0.27 for A549 cells; data
not shown). This type of correlation has been previously
observed for a group of chemically related compounds
(epothilones) in a previous work of our group [33]. These
findings were apparently unexpected since we do not
know the total equilibrium concentration of the drugs
Figure 4. Comparison between Binding Affinity and Microtubule
Stabilization
(A and B) Dependence of the elongation constant of ligand-induced
(A) GTP- or (B) GDP-tubulin assembly, Kel (Kel = 1/Cr) on the free
energy of binding of the ligands to the paclitaxel site. Solid lines
are the best linear regression to the experimental data; dashed
lines are the 95% confidence intervals of the regression. The error
bars indicate standard error.
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other target or binding site for the drugs in the cells.
It is especially noticeable that the IC50 values of many
of the compounds are much lower than their dissocia-
tion constants (1 nM IC50 in 1A9 cells for paclitaxel for
100 nM Kd at 37ºC), which would imply that, unless the
local concentration inside the cell is higher, only a very
small fraction of the tubulin molecules would be bound
by paclitaxel. A possible reason would be drug accumu-
lation due to the high, local tubulin concentration. For
compounds with similar physicochemical properties,
the binding affinity would be the driving force to pass
the membrane.
However, the observed correlation is much weaker for
this set of chemically different compounds than for
those observed for epothilones (r2 = 0.76) [33]. It can
be noticed that discodermolide (6) has much lower
cytoxicity than expected from its binding affinity. As
will be discussed below, this compound has a strong en-
tropic contribution to binding (Table 2). Previous results
for a set of epothilone analogs suggested that com-
pounds with a high, favorable entropic contribution to
Figure 5. Comparison between Binding Affinity and Cytotoxicity in
1A9 Cells
(A) Dependence of the IC50 of ligands against 1A9 human ovarian
carcinoma cell lines on the free energy of binding to the paclitaxel
binding site of microtubules.
(B) Dependence of the IC50 of ligands on the enthalpic term of the
free energy of binding to the paclitaxel site. Solid lines are the best
linear regression to the experimental data; dashed lines are the
95% confidence intervals of the regression.
The error bars indicate standard error.binding are less effective at killing tumoral cells than
those with a high, favorable enthalpic contribution [33].
This would be the case for discodermolide.
Since compounds with a high, favorable entropic con-
tribution to binding are less effective at killing tumoral
cells than those with a favorable enthalpic contribution,
it could be suggested that the enthalpic term is more im-
portant in order to get higher cytotoxicity. In fact, al-
though we have to take with caution the dissection of
binding free energies into their entropic and enthalpic
contributions because of enthalpy-entropy compensa-
tions [35], it can be shown that IC50 is better correlated
with DHapp than with DGapp for all of the MSA (Figure
5B; r2 = 0.58 for 1A9 cells; r2 = 0.50 for A549 cells; data
not shown).
As observed in Figure 5B, there are two groups of
compounds: the first group includes those compounds
with high cytotoxicity (including compounds 1–5), and
the other group contains those with medium cytotoxicity
(including compounds 6–9). The estradiol analog (10)
has very low cytotoxicity. Interestingly, the first group
with high cytotoxicity includes compounds with nega-
tive (or only slightly positive) entropic contributions to
the binding; the binding reaction is enthalpy driven. All
of the ligands in the second group with low cytotoxic-
ities have strong positive entropic contributions to bind-
ing, which leads to a more entropy-driven reaction. Nev-
ertheless,DG0app is still high for some of the compounds
in the second group, including eleutherobin or even dis-
codermolide, the compound with the highest affinity for
the site. One factor that could be involved in the low cy-
totoxicity of discodermolide is its predicted hydrophilic-
ity. As the ligand becomes more hydrophilic, it will be
more difficulty for it to cross the cellular membrane by
passive diffusion, and its cytotoxicity will decrease.
The binding affinity, expressed as the Gibbs free en-
ergy change (DG) (Ka = exp[2DG/RT]), arises from the
sum of two terms (DG = DH 2 TDS): the enthalpic (DH)
and the entropic one (2TDS). Obviously, an increase of
the binding affinity can be accomplished by making ei-
ther DH more negative or DS more positive. Different
compounds may have similar binding constants, which
may arise from different contributions of the enthalpic
and the entropic terms to the free energy, which, in
turn, may be reflected in differential effects into the mi-
crotubule assembly properties and cytotoxicity of the
compounds.
From the results obtained, it can be deduced that DH
is a better predictor of the IC50 than DG for these chem-
ically unrelated ligands. (Interestingly, the cytotoxic ef-
fect is not related to the microtubule thermodynamic
stabilizing effect of the ligands; there is no correlation
between Kel and IC50 [r
2 = 0.008], which indicates that
in vitro microtubule stabilization is not a predictor of cy-
totoxicity). Since the binding enthalpy is the term that
predominantly reflects the strength of the interactions
of the ligand with its target relative to the solvent [36],
it could be suggested that ligands with a high enthalpic
contribution to binding will produce stronger effects on
tubulin and that this will be reflected in the subsequent
microtubule-mediated effects, leading to cytotoxicity.
Since no relationship between microtubule stabilization/
bundling in cells and IC50 was qualitatively observed, the
results suggest that the cytotoxic effect might be related
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rational drug design, complete thermodynamic binding
profiles of ligand binding must be examined, and the en-
thalpic contribution to binding must be maximized in or-
der to get compounds with higher cytotoxic properties.
Significance
The biochemical mechanisms and the thermodynam-
ics of the interaction of microtubules with paclitaxel-
site ligands have been studied. Laulimalide and pe-
loruside A are known to thermodynamically stabilize
microtubules by binding to a site distinct from the pac-
litaxel site. Taccalonolides A and E, dicumarol, lutein,
and jatrophane polyesters have not been found to be
able to induce or modulate in vitro microtubule assem-
bly or to displace a fluorescent taxoid (Flutax-2) from
its binding site, suggesting that the microtubule-stabi-
lizing activity of these compounds, if any, comes
through interactions with other factors regulating cel-
lular microtubule polymer mass rather than by direct
binding to microtubules. The ligands that bind to the
paclitaxel site, including epothilones, eleutherobin,
discodermolide, sarcodictyins, a estradiol analog, dic-
tyostatin, and cyclostreptin (which binds covalently),
require Mg+2 to induce assembly and were able to in-
duce GTP-tubulin assembly under conditions in which
tubulin itself is unable; moreover, the strongest com-
pounds also induced GDP-tubulin assembly. The equi-
librium binding constants of the compounds to the
paclitaxel site, the critical concentrations of ligand-
induced assembly, and their IC50 in 1A9 and A549 cells
have been measured. Correlations between these
parameters have also been explored. The binding is
exothermic for all ligands. Taxoids and epothilones
have unfavorable entropic contributions to binding,
whereas the rest (including discodermolide, which is
expected to have a large conformational freedom in
solution) have favorable entropy changes. The binding
constants weakly correlate with cytotoxicity (IC50) val-
ues in two cell lines: 1A9 and A549 (r2 = 0.31 for 1A9
cells and r2 = 0.27 for A549 cells). Interestingly, IC50
correlates better with the apparent enthalpy of binding
(r2 = 0.58 for 1A9 cells and r2 = 0.50 for A549 cells), sug-
gesting a predictive value of enthalpic contributions to
the free energy of binding in designing paclitaxel-site
drugs with higher cytotoxicity.
Experimental Procedures
Proteins and Ligands
Purified calf brain tubulin, bovine brain microtubule proteins, and
chemicals were prepared as described [37, 38]. Paclitaxel (Taxol)
was provided by the late M. Suffness from the National Cancer Insti-
tute (Bethesda, MD). Docetaxel (Taxotere) was kindly provided by
Rhoˆne Poulenc Rorer, Aventis (Schiltigheim, France). Epothilones,
sarcodictyins, and eleutherobin were provided by K.C. Nicolaou
from the Department of Chemistry and Biochemistry, University of
California, San Diego and the Scripps Research Institute (La Jolla,
CA). Lonafarnib was provided by W.R. Bishop (Schering-Plough Re-
search Institute). Cyclostreptin was provided by E.J. Sorensen
(Princenton University, Princenton, NJ), and the estradiol analog
was provided by E. Hamel from the National Institutes of Health
(Frederick, MD). Jatrophane polyesters were provided by G. Appen-
dino, Universita` del Piemonte Orientale, Italy. Lutein and dicumarol
were purchased from Sigma. Flutax-2 was provided by F. Amat-Guerri from Instituto de Quı´mica Orga´nica (Madrid, Spain). Taccalo-
nolides were isolated as described [22]. Dictyostatin and discoder-
molide were synthesized as described [19, 39]. All of the compounds
were diluted in DMSO to a final concentration of 10 mM and were
stored at 220ºC.
Ligand-Induced Tubulin Assembly
The critical concentrations of ligand-induced tubulin assembly were
measured in PEDTA4-GTP (10 mM sodium phosphate, 1 mM EDTA,
1 mM GDP, 1 mM GTP [pH 6.7] with 4 mM MgCl2) or PEDTA4-GDP
(10 mM sodium phosphate, 1 mM EDTA, 1 mM GDP [pH 7.0] with
4 mM MgCl2). Control experiments have shown that, in these buf-
fers, tubulin concentrations of up to 200 mM do not assemble in
the absence of exogenous ligands [37]. GTP- or GDP-tubulin (pre-
pared as described in [37]) at several concentrations (usually 5–8)
ranging between 1 and 60 mM (depending on the ligand) were incu-
bated at 37ºC for 30 min in the presence of the ligand at a concentra-
tion 10% in excess of the tubulin. The polymers were sedimented at
90,000 3 g for 20 min in a TLA 100 rotor that was preequilibrated at
37ºC in a Beckman Optima TLX ultracentrifuge. The supernatants
were carefully removed by pipetting, and the pellets were resus-
pended in 10 mM phosphate, 1% SDS (pH 7.0). The pellets and
the supernatants were diluted 1:10 in the same buffer, and their con-
centrations were fluorimetrically measured by employing a Fluorolog
3 spectrofluorimeter (excitation wavelength 285 nm and emission
wavelength 320 nm using slits of 2 and 5 nm, respectively). Tubulin
concentration standard curves were constructed for each experi-
ment by using spectrophotometrically measured concentrations of
purified tubulin. Considering a noncovalent nucleation-condensa-
tion polymerization, the critical concentration is equal to the concen-
tration of tubulin in the supernatant (that should be equal to the tu-
bulin concentration given by the extrapolation to zero of the plot
concentration of tubulin in the pellets versus total concentration)
[34]. Apparent polymer growth equilibrium constants were esti-
mated as the reciprocal critical concentrations for polymerization
[34]. The assembled polymers were observed by electron micros-
copy as described below.
Effects of Ligands on Microtubule Assembly and Stability
The effects of the ligands on tubulin assembly were monitored by in-
cubating concentrations from 10 to 20 mM tubulin in buffer GAB-1
mM GTP in the presence of 11 or 22 mM ligand. In this buffer, tubulin
can assemble without ligand with a critical concentration of 3.3 mM.
The samples were processed as described above, and the tubulin
concentrations were also measured fluorometrically as described
above.
The effect of the ligand on polymerization was also tested in
a MAP-containing system; microtubular protein (1 mg/ml) was incu-
bated in buffer AB-1 mM GTP (100 mM MES, 1 mM EGTA, 1 mM
MgSO4, 2 mM 2-mercaptoethanol, 1 mM GTP [pH 6.5]) for 30 min
at 37ºC in the presence of 11 mM ligand. The polymers were then pel-
leted at 90,000 3 g for 20 min in a TLA 100 rotor that was preequili-
brated at 37ºC in a Beckman Optima TLX ultracentrifuge. The super-
natants were taken, the pellets were resuspended in 10 mM sodium
phosphate (pH 7.0), and microtubular protein concentrations were
measured by the method described by Bradford [40] by using BSA
(bovine serum albumin) as standard.
Preparation of Stabilized Microtubules
Stabilized, crosslinked microtubules were prepared by mild cross-
linking with 0.2% glutaraldehyde; the excess of glutaraldehyde
was quenched with NaBH4 (Fluka), and the solution was dialyzed
overnight by using Slide-A-Lyzer 10K dialysis cassettes (Pierce)
against the desired buffer and drop frozen in liquid nitrogen [29,
31]. After this treatment, 90% of the tubulin was found to have
been incorporated into the microtubules that are stable against dilu-
tion and low temperatures. The concentration of paclitaxel binding
sites in these crosslinked microtubules was determined as de-
scribed [29]; 100% of the assembled tubulin dimers were found to
bind taxoids immediately after dialysis.
Binding of Ligands to Microtubules
Samples containing ligand and either stabilized, crosslinked micro-
tubules (prepared as described before) or native ones (polymerized
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1278in GAB-1 mM GTP buffer) were incubated for 30 min at 25ºC in poly-
carbonate centrifuge tubes (Beckman) in GAB/0.1 mM GTP or GAB/
1 mM GTP buffer (DMSO concentration was always kept under 2%).
The samples were then centrifuged at 90,000 3 g for 10 min at 25ºC
in a TLA100 rotor employing a Beckman Optima TLX ultracentrifuge.
The supernatants were collected by pipetting, and the pellets were
resuspended in 10 mM phosphate (pH 7.0). Both the pellets and
supernatants were extracted three times with an excess volume of
dichloromethane, dried in vacuum, and dissolved in 25 ml of a meth-
anol/water (v/v: 70/30) mixture. Ligands bound to pelleted polymers
and free in the supernatant were determined by HPLC. HPLC analy-
sis of the samples was performed in a C-18 column (Supercosil,
LC18-DB, 250 3 4.6 mm, 5 mM bead size) developed isocratically
with 70% methanol, or 50% acetonitrile, in water (v/v) at a flow
rate of 1 ml/min.
Binding of Flutax-2 to stabilized, crosslinked microtubules in the
presence of taccalonolides was also measured by centrifugation.
Samples containing 1 mM taxoid binding sites and 500 nM Flutax-2
in GAB/0.1 mM GTP buffer were incubated at 37ºC for 2 hr with
100 mM taccalonolide A or E and an equal amount of DMSO. The
samples were then centrifuged at 90,000 3 g for 10 min at 37ºC in
a TLA100 rotor employing a Beckman Optima TLX ultracentrifuge.
The supernatants were collected by pipetting, and the pellets were
resuspended in 10 mM phosphate (pH 7.0). The concentrations of
Flutax-2 were fluorimetrically measured by employing a Fluorolog
3 spectrofluorimeter (excitation wavelength 495 nm, emission wave-
length 520 nm using slits of 2 and 5 nm respectively). Flutax-2
concentration standard curves were constructed for each experi-
ment by using spectrophotometrically measured concentrations of
Flutax-2.
Equilibrium Binding Constants of the Ligands to Microtubules
The equilibrium binding constants of the different ligands to the pac-
litaxel binding site of assembled microtubules were measured as
described [29]. Binding constants for compounds reversibly dis-
placing Flutax-2 were calculated by using a PC program written by
us (Equigra v5, J.F.D., unpublished software). This program fits the
experimental data by least-squares to the equilibrium binding con-
stant of the ligand investigated, by employing the known values of
the reference ligand Flutax-2. The thermodynamic parameters (ap-
parent DG0, DH0, and DS0) were calculated from the binding con-
stants at different temperatures.
The binding affinity constant for discodermolide was also mea-
sured by HPLC as follows: 65 ml of 10 nM taxoid binding sites in
crosslinked microtubules were incubated for 30 min at 25ºC with in-
creasing concentrations of the ligand. The mixtures were then
centrifuged for 55 min at 45,000 rpm in a Ti45 rotor in a Beckman
XL-90 ultracentrifuge. The supernatants were removed, and the pel-
lets were resuspended in 20 ml of 10 mM sodium phosphate and left
for 1 hr at 4ºC. The supernatants were extracted with 2 3 50 ml di-
chloromethane, and the pellets were extracted with 2 3 20 ml of
the same solvent. After vacuum evaporation of the dichloromethane,
the residues were dissolved in 30 ml 70% methanol in water (v/v).
HPLC analysis was performed as described above.
Cell Culture
Human ovarian carcinoma 1A9, non-small cell lung carcinoma A549
cells, and monocytic leukemia U937 cells were cultured at 37ºC in
RPMI-1640 supplemented with 10% fetal calf serum, 2 mM L-gluta-
mine, 40 mg/ml gentamycin, 100 IU/ml penicillin, and 100 mg/ml
streptomycin in a 5% CO2 air atmosphere.
Indirect Immunofluorescence
A549 cells were plated at a density of 100,000 cells/ml onto 12 mm
round coverslips, cultured overnight, and then treated with the li-
gands at different concentrations or drug vehicle (DMSO) for 24 hr.
Residual DMSO was less than 0.5%. Attached A549 cells were per-
meabilized with Triton X-100 and fixed with 3.7% formaldehyde, as
previously described [31, 41]. Cytoskeletons were incubated with
a DM1A monoclonal antibody reacting with a-tubulin, washed twice,
and incubated with FITC goat anti-mouse immunoglobulins. The
coverslips were washed, 1 mg/ml Hoechst 33342 was added to stain
chromatin, washed, examined, and photographed with a Zeiss Axio-plan epifluorescence microscope, and the images were recorded
with a Hamamatsu 4742-95 cooled CCD camera.
Cell Cytotoxicity Assay
1A9 or A549 cells were seeded in 96-well plates at a density of 10,000
cells in 0.05 ml per well. On the next day, cells were exposed to 0.05
ml serial dilutions (0.005 nM–40 mM) of ligands for 72 hr, at which
time an MTT assay [42] was performed to determine viable cells
with some modifications. Briefly, 20 ml of 2.5 mg/ml MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) was added
to each well, incubated for 4 hr at 37ºC, and then treated with
0.1 ml MTT solubilizer (10% SDS, 45% dimethylformamide [pH
5.5]). Plates were again incubated overnight at 37ºC to solubilize
the blue formazan precipitate before measuring the absorbance at
595/690 nm in an automated Multiscan microplate reader. Control
wells containing medium without cells were used as blanks. The MTT
response is expressed as a percentage of the control (untreated)
cells. The IC50 was calculated from the log-dose response curves
and expressed as the mean of at least four independent experiments
6 standard deviation.
Cell Cycle Analysis
Progression through the cell cycle was assessed by flow cytometry
DNA determination with propidium iodide. U937 cells (300,000 per
ml) were incubated with several concentrations of the drugs for 20
hr. The cells were fixed with 70% ethanol, treated with RNase, and
stained with propidium iodide as previously described [31]; analysis
was conducted with a Coulter Epics XL flow cytometer.
Electron Microscopy
Aliquots of GTP-tubulin solutions (10–20 mM) incubated with the li-
gand in PEDTA4-1 mM GTP buffer at 37ºC for 30 min were adsorbed
onto formvar/carbon-coated 300 mesh copper grids, stained with
1% uranyl acetate, and observed with a Jeol 1230 transmission elec-
tron microscope (JEOL, Tokyo, Japan).
Supplemental Data
Supplemental Data including cell cycle distribution of U937 cells
treated with ligands are available at http://www.chembiol.com/cgi/
content/full/12/12/1269/DC1/.
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